Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q3 2013 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VAPOTHERM INC | 12 | Q3 2022 | 38.0% |
RENALYTIX PLC | 9 | Q3 2022 | 9.8% |
ALPHATEC HLDGS INC | 8 | Q3 2022 | 7.6% |
EVENTBRITE INC | 8 | Q3 2021 | 5.9% |
TPI COMPOSITES INC | 7 | Q2 2020 | 14.1% |
NEURONETICS INC | 7 | Q3 2022 | 10.5% |
BERKELEY LTS INC | 7 | Q3 2022 | 8.7% |
AXONICS MODULATION TECHNOLOG | 7 | Q2 2021 | 5.7% |
CVRX INC | 6 | Q3 2022 | 14.6% |
STEREOTAXIS INC | 6 | Q3 2022 | 6.1% |
View Parian Global Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Neuronetics, Inc. | February 13, 2023 | 760,410 | 2.8% |
ARTELO BIOSCIENCES, INC.Sold out | February 09, 2022 | 0 | 0.0% |
Humacyte, Inc.Sold out | February 09, 2022 | 0 | 0.0% |
ACACIA RESEARCH CORPSold out | June 24, 2021 | 0 | 0.0% |
Alpha Healthcare Acquisition Corp. | March 01, 2021 | 844,734 | 8.2% |
Blue Apron Holdings, Inc. | February 28, 2020 | 348,900 | 4.3% |
View Parian Global Management LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-02-14 |
SC 13G/A | 2023-02-13 |
SC 13G/A | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
SC 13G/A | 2022-02-09 |
SC 13G/A | 2022-02-09 |
SC 13G/A | 2022-02-09 |
View Parian Global Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.